Brief: Healius Requests Trading Halt
24/09/2026 24:44
BRIEF-Healius Requests Trading Halt Sept 24 (Reuters) - Healius Limited HLS.AX:
TRADING HALT REQUESTED PENDING ANNOUNCEMENT ON AGILEX BIOLABS SALE PROCESS
Further company coverage: HLS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Healius
See all newsAustralia's Healius rises on sale of unit Agilex; Jefferies lifts PT
Brief: Healius To Sell Agilex Biolabs To Novotech
Australia's Healius rises on sale of unit Agilex Biolabs to Novotech Health
Brief: Healius Requests Trading Halt
Brief: Healius Expects To Achieve T27 Target Of Mid-To-High Single-Digit EBIT Margins By Dec 2028